207 related articles for article (PubMed ID: 21853343)
1. Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.
Grimm M; Lazariotou M
Med Oncol; 2012 Sep; 29(3):1435-47. PubMed ID: 21853343
[TBL] [Abstract][Full Text] [Related]
2. Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade.
Zhu DW; Liu Y; Yang X; Yang CZ; Ma J; Yang X; Qiao JK; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
BMC Cancer; 2013 Jun; 13():301. PubMed ID: 23786757
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
4. Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.
Grimm M; Rieth J; Hoefert S; Krimmel M; Rieth S; Teriete P; Kluba S; Biegner T; Munz A; Reinert S
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3371-84. PubMed ID: 26926692
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma.
Grimm M; Krimmel M; Alexander D; Munz A; Kluba S; Keutel C; Hoffmann J; Polligkeit J; Reinert S; Hoefert S
Clin Oral Investig; 2013 Apr; 17(3):949-55. PubMed ID: 22782258
[TBL] [Abstract][Full Text] [Related]
6. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma.
Jiang L; Huang R; Wu Y; Diao P; Zhang W; Li J; Li Z; Wang Y; Cheng J; Yang J
Pathology; 2019 Jan; 51(1):74-80. PubMed ID: 30473182
[TBL] [Abstract][Full Text] [Related]
9. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
10. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
11. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.
Fang HY; Huang XY; Chien HT; Chang JT; Liao CT; Huang JJ; Wei FC; Wang HM; Chen IH; Kang CJ; Huang SF
Laryngoscope; 2013 Nov; 123(11):2690-9. PubMed ID: 23619955
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of preoperative serum C-reactive protein in oral squamous cell carcinoma.
Acharya S; Kale J; Hallikeri K; Anehosur V; Arnold D
Int J Oral Maxillofac Surg; 2018 Jan; 47(1):16-23. PubMed ID: 28716471
[TBL] [Abstract][Full Text] [Related]
13. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
14. A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.
Chen S; Yang X; Feng JF
Oncotarget; 2016 Sep; 7(38):62123-62132. PubMed ID: 27557504
[TBL] [Abstract][Full Text] [Related]
15. ATG9A overexpression is associated with disease recurrence and poor survival in patients with oral squamous cell carcinoma.
Tang JY; Hsi E; Huang YC; Hsu NC; Chen YK; Chu PY; Chai CY
Virchows Arch; 2013 Dec; 463(6):737-42. PubMed ID: 24085552
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.
Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J
Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749
[TBL] [Abstract][Full Text] [Related]
17. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
18. Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis.
Rah YC; Ahn JC; Jeon EH; Kim H; Paik JH; Jeong WJ; Kwon SY; Ahn SH
Int J Clin Oncol; 2018 Oct; 23(5):851-859. PubMed ID: 29761306
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC.
Grimm M
Clin Transl Oncol; 2012 Nov; 14(11):870-80. PubMed ID: 22855158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
